Sharon Mates, Chairman, President & CEO at Intra-Cellular Therapies, Inc. (ITCI), sold 83,790 shares at $26.16 ($2.2M) on 2020-01-09, disclosed to the SEC on 2020-01-10.
Seasonal sale ($2.2M) by Chairman, President & CEO — this insider has traded ITCI in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.16 | 41,895 | $1.1M | 50.0% |
| 2 | $26.16 | 41,895 | $1.1M | 50.0% |
| Total | $26.16 avg | 83,790 | $2.2M | 100% |
| Filing → |
| ITCI | SELL | 2024-08-28 | $14.1M | — | Filing → |
| ITCI | SELL | 2024-08-23 | $18.0M | — | Filing → |
| ITCI | SELL | 2024-03-11 | $8.1M | — | Filing → |